Wouter W. Mellema
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 07, 2015
Difference in outcome between types of KRAS mutation may point toward difference in tumor biology.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 23, 2015
Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: a case report.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 03, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.
Journal: Journal of extracellular vesicles
Published: August 06, 2014
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
Journal: International journal of cancer
Published: May 07, 2014
Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 06, 2014
EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 15, 2013
KRAS mutations in advanced nonsquamous non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive value.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 22, 2013
A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 11, 2012
Low molecular weight heparins in the treatment of lung cancer.
Journal: Expert opinion on investigational drugs
Published: October 08, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026